Introduction
The sex-reversal disorder XY gonadal dysgenesis is the result of an embryonic testicular regression sequence, and can occur in a complete or incomplete form. The complete form is defined by a 46,XY karyotype and the absence of testes. Affected individuals present with female-type external genitalia, normal Müllerian structures, and streak gonads similar to those of Turner syndrome. Gynecologists tend to encounter the complete form, as affected patients grow as phenotypically normal females and at adolescence complain of gynecologic symptoms, such as primary amenorrhea or delayed puberty. In contrast, patients with the incomplete form are often diagnosed in early childhood due to genital ambiguity. The incomplete form is characterized by unilateral or bilateral dysgenetic gonads consisting of disorganized seminiferous tubules admixed with ovarian stroma (Marcantonio et al. 1994) .
Several genetic loci play important roles in testisdetermining pathways. The testis-determining gene SRY is a Y-chromosome gene essential for testicular development (Koopman et al. 1991) . SRY consists of a single exon in which the central third of the open reading frame (ORF) encodes a 79-amino-acid region showing high similarity to a motif known as the high-mobility-group (HMG) box. While the SRY HMG-box-containing protein has been shown to possess sequence-specific DNA-binding activity and act as a transcriptional regulator (Gubbay et al. 1990; Harley et al. 1994) , its target genes remain largely unknown.
Following the cloning of SRY, a number of aberrations, such as missense mutations, nonsense mutations, frameshifts due to nucleotide deletions, and cryptic deletions involving the SRY locus on the short arm of the Y chromosome (Yp), have been reported in patients with XY gonadal dysgenesis (Cameron and Sinclair 1997) . These Abstract XY gonadal dysgenesis can be classified as either complete or incomplete according to gonadal morphology. The disease is a sex-reversal disorder resulting from embryonic testicular regression sequences and is induced by mutations in the sex-determining region Y (SRY) gene. The incidence of SRY mutations is thought to be approximately 20%. As the disease is characterized by a frequent complication of gonadal tumors, patients are usually advised to undergo prophylactic gonadectomy. In this study, we searched for mutations in SRY open reading frames from three patients with the complete form of XY gonadal dysgenesis, and detected missense mutations in two patients. Combined with the results of our previous study, in which SRY abnormalities were also detected in two out of three complete-type patients, the final incidence of SRY abnormalities was 67% (four of six patients), which is much higher than previously thought. The incidence of gonadal tumor formation in patients with SRY abnormalities was 50% (two of four patients), which is similar to the result of a metanalysis of patients with SRY abnormalities that revealed an incidence of 52.5%. Therefore, it is possible that the lower incidences of SRY abnormalities previously reported were caused by the inclusion of patients with the incomplete form or other sex-reversal disorders. Moreover, our results suggest that clinicians should carefully examine patients with SRY abnormalities. aberrations occur especially in the SRY HMG box, and are thought to have an overall incidence of approximately 20%. To date, there have been at least 35 different missense or nonsense mutations reported for SRY (Okuhara et al. 2000) .
It is well known that germ cell tumors, including gonadoblastoma and dysgerminoma, frequently occur in patients with XY gonadal dysgenesis. Gonadoblastoma is a mixed germ cell-sex cord stromal tumor with limited malignancy potential. The tumor arises in streak gonads in 30% of XY sex-reversed patients (Scully 1970; Verp and Simpson 1987) . It has been reported that gonadoblastoma can occur not only in individuals with XY gonadal dysgenesis but also in Turner syndrome patients with mosaic karyotypes that include structurally aberrant Y chromosome clones. Therefore, it has been hypothesized that the expression of a Y chromosome gene (or genes) is involved in tumor etiology (Page 1987) . In a certain number of patients, gonadoblastoma can also develop into dysgerminoma (Manuel et al. 1976 ), a malignant germ cell tumor that can lead to metastatic disease. As the reason for the association between XY gonadal dysgenesis and gonadal tumors remains unclear, many patients are advised to undergo prophylactic gonadectomy soon after diagnosis. However, it is not known whether prophylactic gonadectomy is necessary for all patients with the disease. We have previously identified two SRY aberrations (a cryptic deletion of a region of Yp that includes SRY, and a mutation consisting of a 2-base substitution and a 7-base deletion) from three patients with the complete form of XY gonadal dysgenesis (Uehara et al. 1999) , and speculated that these aberrations were associated with gonadal tumors. We have now examined for SRY mutations three additional independent patients with the complete form of the disease. We detected two missense mutations, both in the SRY HMG box. On the basis of the present results and a metanalysis of previous reports, we discuss the incidence of SRY aberrations and the relationship between SRY aberrations and gonadal tumor formation, especially in patients with complete-type XY gonadal dysgenesis.
Subjects and methods

Clinical reports
We encountered three new patients (NH, MF, and YS) with the complete form of XY gonadal dysgenesis. All three patients complained of primary amenorrhea or delayed menarche. The patients were unrelated and their parents were non-consanguineous. By physical examination, the patients were phenotypically female with unambiguous female-type external genitalia, positive development of pubic hair, and hypoplastic uteri. The possibilities of androgen insensitivity or inborn errors of testosterone biosynthesis were excluded by analyses of serum testosterone, androstenedione, and dihydrotestosterone before and after human chorionic gonadotropin stimulation. Other endocrinological examinations revealed hypergonadotropic hypogonadism. The karyotypes of all three patients were 46,XY, as determined from peripheral blood leukocytes stimulated with phytohemagglutinin. Exploratory laparoscopy was performed to determine the presence of Müllerian structures and the nature of the gonadal tissues. Excised gonadal tissues from all three patients were examined by conventional histologic methods, and revealed only fibrous tissue without primitive sex cords. The case reports of the patients are summarized in Table 1 . The patients gave their fully informed consent before being included in this study.
Nucleotide sequencing of SRY Genomic DNA was extracted from peripheral blood samples from the three patients as well as from normal males and females using SepaGene (Sanko-Junyaku, Tokyo, Japan). The entire SRY coding region (SRY-ORF) was amplified from genomic DNA samples by using primers XES10 and XES11, as described by Hawkins et al. (1992a) . Polymerase chain reaction (PCR) products were electrophoresed on 2% agarose gels, purified, and subcloned into the pGEM-T plasmid (Promega, Madison, WI, USA). Plasmids were then transformed into E. coli (DH-5α), and bacterial colonies containing the correct insert identified. Plasmid DNA was prepared and applied to nucleotide sequencing analysis. To distinguish mutations from randomly misincorporated nucleotides, plasmids from six independent bacterial colonies were examined.
Metanalysis
To investigate the incidence of SRY aberrations in patients with XY gonadal dysgenesis, we collected reports that analyzed patient numbers and numbers of SRY abnormalities (References are cited in Table 2 ). DNA sequences from entire SRY-ORFs were screened in these studies. Because the results of clinical examinations, such as gonadal morphology and anatomy of internal genitalia, were not satisfactorily described in some of the previous reports, the subjects possibly included not only patients with the complete form of XY gonadal dysgenesis but also patients with the incomplete form or other sex reversal disorders. To investigate the relationship between SRY aberrations and gonadal tumor formation in XY gonadal dysgenesis, previous reports describing SRY molecular analyses, histopathological findings of resected gonads, and patient age (age was unknown in some reports) were also gathered (References are cited in Table 3 ). 
Results
SRY mutations
Of three previously unreported patients with XY complete gonadal dysgenesis, two patients exhibited SRY point mutations.
In patient HN, the DNA sequence of the entire SRY-ORF was identical to the wild-type sequence obtained from control males.
Patient MF showed a missense mutation within the SRY HMG box, with the arginine codon (CGT) at amino acid 132 altered to a glycine (GGT), giving Arg132CGTAE GlyGGT (Fig. 1A) .
Patient YS also showed a missense mutation within the HMG box, with the alanine codon (GCA) at amino acid position 113 altered to a threonine (ACA), giving Ala113GCAAEThrACA (Fig. 1B) .
The two types of nucleotide substitutions were not detected in our preliminary SRY sequencing of 30 normal males.
Incidence of SRY abnormalities
Metanalysis of 121 patients with XY gonadal dysgenesis revealed that SRY abnormalities (both cryptic deletions in Yp including the SRY locus and SRY mutations) were present in 23 patients (18.5%). This is in contrast to the observed incidence from our studies (67%; four out of six patients). Interestingly, Hawkins et al. (1992a) , who analyzed only patients with the complete form, also reported a higher incidence (60%; three in five patients). Table 2 summarizes patient numbers, SRY abnormalities, and references.
Relationship between SRY abnormalities and gonadal tumor formation In the metanalysis, 40 patients (including four familial cases of two related individuals) were shown to have SRY abnormalities: 7 patients with cryptic deletions involving Yp, and 33 patients with SRY mutations, including missense mutations, nonsense mutations, deletions, and frameshifts. Most of the SRY mutations were located within the SRY HMG box, with only three mutations located outside. Of the 40 patients with SRY abnormalities, 21 (52.5%) had complications in the form of gonadal tumors, with gonadoblastoma observed in 13 patients, malignant tumors (including dysgerminoma, with or without gonadoblastoma, and embryonal carcinoma) in 7 patients, and fibroma in 1 patient. Bilateral streak gonads without tumors were observed in 19 patients. Age, details of the aberration, whether the aberrant site was inside or outside the SRY HMG box, histopathological findings on gonads, and references are summarized in Table 3 .
Discussion
In the present study, we detected two missense mutations in two out of the three new patients: Arg132CGTAEGlyGGT was a novel mutation, while Ala113GCAAEThrACA was reported by Zeng et al. (1993) . We have previously reported finding SRY abnormalities in two out of three patients with the complete form of XY gonadal dysgenesis (Uehara et al. 1999) ; thus, the final proportion of SRY aberrations was 67% (four of six patients). While this proportion is much higher than that observed in previous reports (Table 2) , our result was similar (60%; three in five patients) to that reported by Hawkins et al. (1992a) , who also analyzed only patients with the complete form. XY sex reversal can be induced by several other etiologies, including microdeletions in Yp, androgen-insensitivity syndrome, LH receptor deficiency, P450c17 deficiency, and so on. Furthermore, XY gonadal dysgenesis can be classified as being either complete or incomplete. In our study, subjects were limited only to patients diagnosed with the complete form by means of physical, endocrinological, surgical, and histopathological examinations. Thus, the finding of a much higher proportion of SRY abnormalities in a group of patients carefully selected as having the complete form may be significant. It is possible, therefore, that some patients classified as having "gonadal dysgenesis" in some previous reports may in fact have had the incomplete form or some other disorder, and a high incidence of SRY abnormality may be a characteristic of the complete form.
However, the fact remains that some patients in the metanalysis showed no SRY mutations. Although the etiologies for these patients could not be ascertained, McElreavey et al. (1996) reported a case that showed a cryptic and interstitial deletion upstream of SRY (i.e., outside the SRY-ORF region), and Kwok et al. (1996) included a case with a single-base variant upstream of SRY. There- fore, as with other complete-form etiologies, it is possible that the aberrations were present in the SRY activatorbinding or promoter regions.
As shown in Table 3 , the complete form can be induced by various SRY point mutations. However, the incomplete form is more likely to be induced by SRY missense mutations outside the HMG-box region (Domenice et al. 1998) . Moreover, the Val60GTGAEAlaGCG missense mutation in the SRY HMG box (shown to be not a polymorphism but a mutation after analysis of 200 normal males) was identified in a true hermaphrodite whose one gonad was an ovotestis (Hiort and Klauber 1995) . Therefore, it is possible that variations in gonadal morphology and phenotype may be due to residual bioactivity of the substituted SRY protein, so that the entire SRY-ORF should be analyzed to determine the etiologies of XY gonadal dysgenesis or true hermaphroditism.
The results of the metanalysis concerning the relationship between SRY aberrations and gonadal tumor formation (Table 3) showed that benign and malignant gonadal tumors were observed in 21 out of 40 (52.5%) patients with SRY abnormalities. In light of this high incidence, it is possible that aberrant SRY proteins are involved in gonadal tumor formation in XY gonadal dysgenesis. However, Page (1987) , who hypothesized the presence of a locus GBY (gonadoblastoma locus on the Y chromosome), predicted that the gene encoded by the GBY locus would function normally in the testis but act as an oncogene only in the dysgenetic gonad. Until now, the GBY locus has been mapped to the small pericentric region (1-2 Mb of DNA). Five genes (amelogenin Y, RNA-binding Y, protein kinase Y, protein tyrosine phosphatase-related Y, and testisspecific protein Y-encoded) residing on that small region are candidates for GBY (Vogt et al. 1997; Lahn and Page 1997; Lau and Zhang 2000) . A patient with an idic(Y)(q11.23) karyotype that preserved the critical region of GBY showed gonadoblastoma formation (Giltay et al. 2001) , supporting the interpretation of GBY as an oncogene that affects gonadal tumor formation.
The incidence of gonadoblastoma formation increases with age in XY sex reversal patients (Manuel et al. 1976) . Indeed, as shown in Table 3 , in the two familial cases with SRY point mutations, the older patients exhibited gonadal tumors whereas the younger patients did not (Tajima et al. 1994; Schmitt-Ney et al. 1995) . As neoplastic initiation may be induced by multiple mutations of related genes (Knudson 1971 (Knudson , 1972 , it has been hypothesized that mutations in oncogenes, tumor suppressor genes, or DNA repair genes accumulate with age and then induce tumor formation as well as other neoplasms in the streak gonads. It has been shown that although SRY plays a role in gonadal development, the target genes for the SRY protein remain unclear. Of the six patients that we studied, malignant dysgerminoma lesions were observed in two patients (15 and 22 years old), both with aberrant SRY, but no tumor formation was observed in the two older patients (22 and 33 years old) with normal SRY. On the basis of these results, it appears that patients with SRY aberrations have a greater risk for gonadal tumor formation than patients without SRY aberrations. Therefore, as SRY may function as an oncogene as well as GBY, it is recommended that clinicians carefully examine and observe the gonads of patients with SRY aberrations.
